When selecting a Randomization and Trial Supply Management (RTSM) system, are you balancing short-term efficiency with long-term success? Timeline efficiency..
Author: Naor Chazan
Korio Welcomes Jonathan Andrus to Board of Directors
DOYLESTOWN, Pa., April 8, 2025 — Korio, Inc., the pioneering Randomization & Trial Supply Management (RTSM) technology company, today announced..
Korio Introduces Mid-Study RTSM Migration Solution for Sponsors Seeking Vendor Change
Feeling Trapped by your Current RTSM Solution? How to exit your provider with minimal disruption. Doylestown, PA – March..
3 Reasons Sponsors Should Own the RTSM Relationship
While many Sponsors rely on CROs for most clinical development functions, delegating RTSM vendor selection and management may create undesirable..
When Innovation Meets RTSM: Navigating New Requirements Through True Partnership
In a recent episode of RTSM Time, host Paul Hughes, Director of RTSM at Johnson & Johnson, sat down with..
Infographic: Anatomy of RTSM Change Requests
Ever wonder why your “quick” RTSM change took 3 months? The truth is: these frustrating delays aren’t inevitable. They’re symptoms..
Anatomy of RTSM Change Requests: How Modern Platforms Are Eliminating Delays
Learn why RTSM change requests take months with legacy systems, and how Korio’s modern platform reduces timelines from weeks to days. Discover the bottlenecks slowing your clinical trials.
Automation Testing in RTSM Software: What It Is, and Why It Can Impact Your Trial Timelines and System Quality
Explore how RTSM testing automation enhances clinical trial efficiency. Learn about improved focus, coverage, consistency, and speed in randomization and trial supply management.
Korio Secures Series A Funding to Accelerate Growth of Innovative Randomization & Trial Supply Management (RTSM) Platform
Korio to support patient enrollment and randomization for first randomized sub study in the trial.
Korio’s Next-Generation RTSM Platform Selected For The Leukemia & Lymphoma Society’s Beat AML® Master Clinical Trial
Korio to support patient enrollment and randomization for first randomized sub study in the trial.